Filgotinib in combination with methotrexate or as monotherapy versus methotrexate monotherapy in patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: the phase 3, randomised controlled FINCH 3 trial
René Westhovens, William F. C. Rigby, Désirée van der Heijde, D. W. T. CHING, William Stohl, Jonathan Kay, Arvind Chopra, Beatrix Bartók, F. Matzkies, Zhaoyu Yin, Ying Guo, Chantal Tasset, John S. Sundy, Angelika Jahreis, Neelufar Mozaffarian, Osvaldo Daniel Messina, Robert Landewé, Tatsuya Atsumi, Gerd R Burmester
Topics & Concepts
MedicineMethotrexateRheumatoid arthritisInternal medicineClinical endpointAdverse effectRheumatologyGastroenterologyArthritisClinical trialRheumatoid Arthritis Research and TherapiesSpondyloarthritis Studies and TreatmentsAutoimmune and Inflammatory Disorders Research